Ibrahim Ramy Riad Ahmed
President, PDT BU
Ibrahim Ramy Riad Ahmed has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Ibrahim Ramy Riad Ahmed is listed as President, PDT BU at TAKEDA PHARMACEUTICAL CO LTD. Inside the rolling window, Ibrahim Ramy Riad Ahmed reported no open-market purchases and 1 open-market sale totaling $124K in TAK.
Companies traded
Other insiders at TAK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$124K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ibrahim Ramy Riad Ahmed made?
Ibrahim Ramy Riad Ahmed has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Ibrahim Ramy Riad Ahmed trade?
Ibrahim Ramy Riad Ahmed has filed SEC Form 4 disclosures for 1 company, including TAK.
When was Ibrahim Ramy Riad Ahmed's most recent SEC Form 4 filing?
Ibrahim Ramy Riad Ahmed's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Ibrahim Ramy Riad Ahmed's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ibrahim Ramy Riad Ahmed is listed as President, PDT BU.
What is Ibrahim Ramy Riad Ahmed's total buy and sell value in the current window?
Inside the rolling retention window, Ibrahim Ramy Riad Ahmed bought $0 and sold $124K based on SEC Form 4 filings.
What was Ibrahim Ramy Riad Ahmed's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,277 TAK shares on 2026-08-10, worth $124K, per SEC Form 4 filings.